Radiotherapy is one of the cornerstones of cancer treatment, being a component of management in at least half of all cancer patients. Increasingly, radiotherapy is used in multimodal treatment protocols in combination with surgery and chemotherapy. The best outcomes are achieved when specialists in each of these disciplines work in a multidisciplinary way, understanding the benefits and limitations that each brings to the patient's management. The aim is to individualise treatment using the best evidence available while continually advancing our knowledge through clinical trials. The Trans-Tasman Radiation Oncology Group has taken a leadership role in this regard.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
